1. Anti-Viral Drug Therapy Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By Drug Class
6.1.3. Segmentation By Application

7. Anti-Viral Drug Therapy Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Drug Class
7.2.1. DNA (Nucleotide) Polymerase Inhibitors
7.2.2. Reverse Transcriptase Inhibitors
7.2.3. Protease Inhibitors
7.2.4. Neuraminidase Inhibitors
7.2.5. Others
7.3. Market Segmentation By Application
7.3.1. HIV
7.3.2. Hepatitis
7.3.3. Herpes
7.3.4. Influenza
7.3.5. Others

8. Anti-Viral Drug Therapy Market Trends And Strategies
8.1. Combination Drug Therapy For Viral Diseases
8.2. Strategic Collaborations And Agreements
8.3. Global Research Initiatives And Funding
8.4. 3D Bioprinting Technology
8.5. Increasing Number Of Pipeline Studies And Drug Development

9. Impact Of COVID-19 On Anti-Viral Drug Therapy Market
9.1. Background
9.2. Drug Therapies
9.3. Antiviral Remdesivir Market Growth

10. Global Anti-Viral Drug Therapy Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2019
10.2.2. Restraints On The Market 2015 - 2019
10.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
10.3.1. Drivers Of The Market 2019 - 2023
10.3.2. Restraints On The Market 2019 - 2023

11. Anti-Viral Drug Therapy Market, Regional And Country Analysis
11.1. Global Anti-Viral Drug Therapy Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
11.2. Global Anti-Viral Drug Therapy Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Billion)

12. Global Anti-Viral Drug Therapy Market Segmentation
12.1. Global Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
12.2. Global Anti-Viral Drug Therapy Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Anti-Viral Drug Therapy Market
13.1. Asia Pacific Anti-Viral Drug Therapy Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. COVID-19 Impact
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Asia-Pacific Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.3. Asia-Pacific Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.4. Asia-Pacific Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Anti-Viral Drug Therapy Market: Country Analysis
13.6. China Anti-Viral Drug Therapy Market
13.7. China Anti-Viral Drug Therapy Market Overview
13.7.1. Country Information
13.7.2. Market Information
13.7.3. COVID-19 Impact
13.7.4. Background Information
13.7.5. Government Initiatives
13.7.6. Regulations
13.7.7. Regulatory Bodies
13.7.8. Major Associations
13.7.9. Taxes levied
13.7.10. Corporate Tax Structure
13.7.11. Investments
13.7.12. Major Companies
13.8. China Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.9. China Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.10. China Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.11. Australia Anti-Viral Drug Therapy Market
13.12. Australia Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.13. Australia Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.14. Australia Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.15. India Anti-Viral Drug Therapy Market
13.16. India Anti-Viral Drug Therapy Market Overview
13.16.1. Country Information
13.16.2. Market Information
13.16.3. COVID-19 Impact
13.16.4. Background Information
13.16.5. Government Initiatives
13.16.6. Regulations
13.16.7. Regulatory Bodies
13.16.8. Major Associations
13.16.9. Taxes levied
13.16.10. Corporate Tax Structure
13.16.11. Investments
13.16.12. Major Companies
13.17. India Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.18. India Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.19. India Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.20. Indonesia Anti-Viral Drug Therapy Market
13.21. Indonesia Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.22. Indonesia Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.23. Indonesia Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.24. Japan Anti-Viral Drug Therapy Market
13.25. Japan Anti-Viral Drug Therapy Market Overview
13.25.1. Country Information
13.25.2. Market Information
13.25.3. COVID-19 Impact
13.25.4. Background Information
13.25.5. Government Initiatives
13.25.6. Regulations
13.25.7. Regulatory Bodies
13.25.8. Major Associations
13.25.9. Taxes levied
13.25.10. Corporate Tax Structure
13.25.11. Investments
13.25.12. Major Companies
13.26. Japan Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.27. Japan Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.28. Japan Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.29. South Korea Anti-Viral Drug Therapy Market
13.30. South Korea Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
13.31. South Korea Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
13.32. South Korea Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Western Europe Anti-Viral Drug Therapy Market
14.1. Western Europe Anti-Viral Drug Therapy Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. COVID-19 Impact
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Western Europe Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
14.3. Western Europe Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
14.4. Western Europe Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Anti-Viral Drug Therapy Market: Country Analysis
14.6. UK Anti-Viral Drug Therapy Market
14.7. UK Anti-Viral Drug Therapy Market Overview
14.7.1. Country Information
14.7.2. Market Information
14.7.3. COVID-19 Impact
14.7.4. Background Information
14.7.5. Government Initiatives
14.7.6. Regulations
14.7.7. Regulatory Bodies
14.7.8. Major Associations
14.7.9. Taxes levied
14.7.10. Corporate Tax Structure
14.7.11. Investments
14.7.12. Major Companies
14.8. UK Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
14.9. UK Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
14.10. UK Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
14.11. France Anti-Viral Drug Therapy Market
14.12. France Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
14.13. France Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
14.14. France Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
14.15. Germany Anti-Viral Drug Therapy Market
14.16. Germany Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
14.17. Germany Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
14.18. Germany Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Anti-Viral Drug Therapy Market
15.1. Eastern Europe Anti-Viral Drug Therapy Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. COVID-19 Impact
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Tax Levied
15.1.9. Associations
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
15.3. Eastern Europe Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
15.4. Eastern Europe Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Anti-Viral Drug Therapy Market: Country Analysis
15.6. Russia Anti-Viral Drug Therapy Market
15.7. Russia Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
15.8. Russia Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
15.9. Russia Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. North America Anti-Viral Drug Therapy Market
16.1. North America Anti-Viral Drug Therapy Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. COVID-19 Impact
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Major Associations
16.1.9. Taxes levied
16.1.10. Corporate Tax Structure
16.1.11. Investments
16.1.12. Major Companies
16.2. North America Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
16.3. North America Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
16.4. North America Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
16.5. North America Anti-Viral Drug Therapy Market: Country Analysis
16.6. USA Anti-Viral Drug Therapy Market
16.7. USA Anti-Viral Drug Therapy Market Overview
16.7.1. Country Information
16.7.2. Market Information
16.7.3. COVID-19 Impact
16.7.4. Background Information
16.7.5. Government Initiatives
16.7.6. Regulations
16.7.7. Regulatory Bodies
16.7.8. Major Associations
16.7.9. Corporate Tax Structure
16.7.10. Investments
16.7.11. Major Companies
16.8. USA Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
16.9. USA Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
16.10. USA Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. South America Anti-Viral Drug Therapy Market
17.1. South America Anti-viral Drug Therapy Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. COVID-19 Impact
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Tax Levied
17.1.9. Associations
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
17.3. South America Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
17.4. South America Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
17.5. South America Anti-Viral Drug Therapy Market: Country Analysis
17.6. Brazil Anti-Viral Drug Therapy Market
17.7. Brazil Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
17.8. Brazil Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
17.9. Brazil Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Middle East Anti-Viral Drug Therapy Market
18.1. Middle East Anti-Viral Drug Therapy Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID-19 Impact
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Major Associations
18.1.8. Taxes Levied
18.1.9. Corporate Tax Structure
18.1.10. Investment
18.1.11. Major Companies
18.2. Middle East Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
18.3. Middle East Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
18.4. Middle East Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Africa Anti-Viral Drug Therapy Market
19.1. Africa Anti-Viral Drug Therapy Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Taxes Levied
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Corporate Tax Structure
19.1.12. Major Companies
19.2. Africa Anti-Viral Drug Therapy Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
19.3. Africa Anti-Viral Drug Therapy Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
19.4. Africa Anti-Viral Drug Therapy Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Global Anti-Viral Drug Therapy Market Competitive Landscape
20.1. Company Profiles
20.2. Gilead Sciences Inc
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. GlaxoSmithKline plc
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Johnson & Johnson
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. AbbVie Inc.
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial overview
20.6. Merck & Co., Inc.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Anti-Viral Drug Therapy Market, Key Mergers And Acquisitions
21.1. Merck and Ridgeback Bio Collaborate
21.2. Gilead Acquired Three Antiviral Portfolios From Novartis
21.3. Johnson & Johnson Acquired Novira Therapeutics, Inc.
21.4. Johnson & Johnson Acquired Alios

22. Anti-Viral Drug Therapy Market Future Outlook and Potential Analysis
22.1. Global Anti-Viral Drug Therapy Market In 2023 - Countries Offering Most New Opportunities
22.2. Global Anti-Viral Drug Therapy Market In 2023 - Segments Offering Most New Opportunities
22.3. Global Anti-Viral Drug Therapy Market In 2023 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Anti-Viral Drug Therapy Market, Conclusions And Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.6. Copyright And Disclaimer

Companies Mentioned
. Gilead Sciences Inc.; GlaxoSmithKline plc; Johnson & Johnson; AbbVie Inc.; Merck & Co.
. Inc.